Estados Unidos · Bolsa y Finanzas · MarketWatch

Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug

Publicado por MarketWatch · Estados Unidos hace 8 h

Genmab shares jumped after the biotechnology company and partner AbbVie said their Epkinly drug helped extend the time patients with a common type of lymphoma lived without the…

Leer el artículo completo en MarketWatch Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketwatch.com)

Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug

También te puede interesar

I'm the CEO of Zocdoc. Here's how long showers help me manage hectic days.

Euro Area retail sales rise 0.8% Y/Y, below estimates

Battle Between Disney and the F.C.C. Moves to the Courts

OKX Money lets users save, earn 10% yield and spend dollar stablecoins in one app

These are the 10 U.S. cities with the most homes at risk of hurricane damage

At Least 50 Iranian Tankers Are Stuck in the Gulf as U.S. Blockade Holds

Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug

Compartir

También te puede interesar

I'm the CEO of Zocdoc. Here's how long showers help me manage hectic days.

Euro Area retail sales rise 0.8% Y/Y, below estimates

Battle Between Disney and the F.C.C. Moves to the Courts

OKX Money lets users save, earn 10% yield and spend dollar stablecoins in one app

These are the 10 U.S. cities with the most homes at risk of hurricane damage

At Least 50 Iranian Tankers Are Stuck in the Gulf as U.S. Blockade Holds